| |
 |
|
Class Information
Number: 514/381
Name: Drug, bio-affecting and body treating compositions > Designated organic active ingredient containing (doai) > Heterocyclic carbon compounds containing a hetero ring having chalcogen (i.e., o,s,se or te) or nitrogen as the only ring hetero atoms doai > Five-membered hetero ring containing at least one nitrogen ring atom (e.g., 1,2,3-triazoles, etc.) > Tetrazoles (including hydrogenated)
Description: Subject matter wherein the five-membered hetero ring consists of four ring nitrogens and one ring carbon and may have double bond between ring members.
Sub-classes under this class:
Patents under this class:
| Patent Number |
Title Of Patent |
Date Issued |
| 6555576 |
Method for treating exercise induced asthma |
Apr. 29, 2003 |
| 6552051 |
Energetic nitramine-linked azoles and related compounds as oxidizers, initiators and gas generators |
Apr. 22, 2003 |
| 6545031 |
Endothelin receptor antagonists |
Apr. 8, 2003 |
| 6538029 |
Methods for treatment of renal cell carcinoma |
Mar. 25, 2003 |
| 6538022 |
Compounds for deactivating phospholamban function on Ca-ATPase (phopholamban inhibitors) |
Mar. 25, 2003 |
| 6531485 |
Prostaglandin agonists |
Mar. 11, 2003 |
| 6525099 |
N-substituted sulfonamide derivatives |
Feb. 25, 2003 |
| 6525073 |
Prevention or treatment of insomnia with a neurokinin-1 receptor antagonist |
Feb. 25, 2003 |
| 6521650 |
Amines as pharmaceutical agents |
Feb. 18, 2003 |
| 6518292 |
Heterocyclic aromatic compounds usefuls as growth hormone secretagogues |
Feb. 11, 2003 |
| 6518289 |
1-substituted-1-aminomethyl-cycloalkane derivatives (=gabapentin analogues), their preparation and their use in the treatment of neurological disorders |
Feb. 11, 2003 |
| 6511670 |
(poly)thiaalkynoic compounds and pharmaceutical/cosmetic compositions comprised thereof |
Jan. 28, 2003 |
| 6509353 |
Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors |
Jan. 21, 2003 |
| 6506738 |
Benzimidazolone antiviral agents |
Jan. 14, 2003 |
| 6500855 |
Thrombin or factor Xa inhibitors |
Dec. 31, 2002 |
| 6500853 |
Inhibitors of phospholipase enzymes |
Dec. 31, 2002 |
| 6498180 |
Excitatory amino acid receptor modulators |
Dec. 24, 2002 |
| 6495580 |
Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases |
Dec. 17, 2002 |
| 6492363 |
2-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives |
Dec. 10, 2002 |
| 6479493 |
Methods for treatment of type I diabetes |
Nov. 12, 2002 |
| 6479518 |
Zwitterionic tachykinin receptor antagonists |
Nov. 12, 2002 |
| 6469037 |
Prophylactic or therapeutic drug for renal diseases |
Oct. 22, 2002 |
| 6465503 |
Selective urokinase inhibitors |
Oct. 15, 2002 |
| 6465502 |
Additional therapeutic use |
Oct. 15, 2002 |
| 6462054 |
Inhibitors of fatty acid amide hydrolase |
Oct. 8, 2002 |
| 6462061 |
Omega chain modified 15-hydroxyeicosatetraenoic acid derivatives and methods of their use for treatment of dry eye |
Oct. 8, 2002 |
| 6455562 |
Cyclic AMP-specific phosphodiesterase inhibitors |
Sep. 24, 2002 |
| 6451832 |
Benzimidazoles with antithrombotic activity |
Sep. 17, 2002 |
| 6451833 |
N-substituted (.alpha.-imidazolyl-toluyl)pyrrole compounds for treatment of circulatory disorders |
Sep. 17, 2002 |
| 6448281 |
Viral polymerase inhibitors |
Sep. 10, 2002 |
| 6448280 |
Angiotensin II antagonists against disorders associated with impaired neuronal conduction velocity, especially diabetic neuropathy |
Sep. 10, 2002 |
| 6444701 |
Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase |
Sep. 3, 2002 |
| 6441015 |
Tetrazole compounds as thyroid receptor ligands |
Aug. 27, 2002 |
| 6436971 |
Use of PDE 4-specific inhibitors to reduce the severity of a bacterial infection after a respiratory viral infection |
Aug. 20, 2002 |
| 6436965 |
PDE IV inhibiting amides, compositions and methods of treatment |
Aug. 20, 2002 |
| 6436974 |
Amino heterocycles useful as pharmaceutical agents |
Aug. 20, 2002 |
| 6426359 |
Prevention and treatment of skeletal disorder with EP2 receptor subtype selective prostaglandin E2 agonists |
Jul. 30, 2002 |
| 6420401 |
1,2,5, thiadiazolidin-3-one 1,1-dioxide derivatives |
Jul. 16, 2002 |
| 6420405 |
Pharmaceutical composition for angiotensin II-mediated diseases |
Jul. 16, 2002 |
| 6417215 |
Calcilytic compounds |
Jul. 9, 2002 |
| 6413996 |
Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
Jul. 2, 2002 |
| 6410542 |
Aminotetrazole derivatives useful as nitric oxide synthase inhibitors |
Jun. 25, 2002 |
| 6407140 |
Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor and a leukotriene A4 hydrolase inhibitor |
Jun. 18, 2002 |
| 6407129 |
Azole compounds, their production and their use |
Jun. 18, 2002 |
| 6403599 |
Corticotropin releasing factor antagonists |
Jun. 11, 2002 |
| 6399641 |
2H-tetrazole-amide compounds with therapeutic activity as metabotropic glutamate receptor agonists |
Jun. 4, 2002 |
| 6395781 |
20-HETE antagonists and agonists |
May. 28, 2002 |
| 6395728 |
Method of treatment and pharmaceutical composition |
May. 28, 2002 |
| 6376533 |
Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
Apr. 23, 2002 |
| 6376524 |
Triphenyl compounds as interleukin-4 antagonists |
Apr. 23, 2002 |
|
|
|
